Pazufloxacin mesylate sodium chloride soft bag dual valve

[Specification] 100ml:0.3g

[Specification] 100ml:0.5g

[Indications] The indications for Pazufloxacin Mesylate Sodium Chloride Injection in a dual-valve soft-bag presentation must be confirmed against the approved product labeling for the specific formulation. A corresponding US FDA-approved prescribing information document could not be verified.

[Usage and dosage] This formulation should be administered intravenously in accordance with its approved prescribing information. The recommended dose, infusion duration, treatment course, and any required dose adjustments must be verified for the specific product strength and presentation.